Ellen
Analyst
TD Cowen
Equibles does not estimate personal net worth.
About Ellen
Ellen is recorded as Analyst at TD Cowen. Ellen has spoken on 1 investor event across 1 company, most recently for Revolution Medicines, Inc. on May 31, 2026. The companies whose calls Ellen spoke on are classified in the Healthcare sector.
Ellen on recent calls
“We noticed that 57% of the patients in the control arm were treated with demobraxane. Have you compared draxon-aracid to this subgroup specifically, and is there any reason to expect that the hazard ratio might differ in the patient's treated with gemobaraxane versus other regimens?”
Affiliation history
-
TD Cowen
Analyst
Transcript header (unverified)
Current